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I. INTRODUCTION 
Thyroid hormones (TH) are crucial regulators of many fundamental biological processes e.g. 
metabolism, neuronal development, growth, stress, reproduction. The daily TH production is 
tightly controlled by the hypothalamus-pituitary-thyroid (HPT) axis keeping serum T3 levels in 
the physiological range. Hypophysiotropic thyrotropin releasing hormone (TRH) neurons, the 
central regulators of the HPT axis, are confined to the medial parvocellular and periventricular 
subdivision of hypothalamic paraventricular nucleus (PVN) in the rat. TRH axon terminals 
expand to external zone median eminence (ME), where they secret the TRH peptide in 
fenestrated portal capillaries that reaches the thyrotropes in anterior pituitary and evokes 
thyroid stimulating hormone (TSH) release into peripheral blood to allow TSH-induced 
stimulation of follicular cells of the thyroid gland. The human thyroid gland produces mainly 
thyroxin (T4) and only in a lesser extent triiodothyronine (T3). To exert it’s biological effect 
the T4 prohormone needs to be activated to T3 that can bind the thyroid hormone receptor 
(TR). TH regulate their own production via negative feedback at the different levels of the HPT 
axis. Serum TH levels are relatively stable but TH action occurs predominantly at the tissue 
level, thus tissue/cell-type specific regulation of TH action needs to be customized by a 
complex regulatory system. This system involves the transport of TH by various TH 
transporters, the activation and inactivation by deiodinase enzyme family that allows to 
customize TH availability, and the regulation of TH action by TH receptors and co-regulators.  
This tissue-specific system is functionally interlinked with the HPT axis in the hypothalamus. 
T4 is the TH form that preferentially transported into the brain thus local activation to T3 is 
especially important, to exert TH action at specific brain regions. In the brain type 2 deiodinase 
(D2)-mediated TH activation and type 3 deiodinase (D3)-catalyzed inactivation is 
compartmentalized between glial cells and neurons, respectively. In the hypothalamus, the 
main T3 generating, D2 expressing cells are tanycytes, the specialized glial cells, lining the 
floor and wall of the third ventricle. While the cell bodies of TRH neurons are located in some 
distance to tanycytes, the axon terminals and tanycyte processes are in close proximity in the 
ME representing a locus where tanycyte derived T3 can act on TRH neurons. This region 
represents also an important role in the regulation of other hypophysiotropic neurosecretory 
neurons like gonadotropin- (GnRH), corticotropin-(CRH), growth hormone- (GHRH) releasing 
hormone neurons, and somatostatin neurons (SST), which expand their axon terminals to this 
region and which are well-known target of TH-s.  
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The reference level of serum TH-s in blood are set by set point formation during development 
and as a consequence the axis is programmed to keep circulation T3 levels in the desired range. 
While tight regulation of TH levels during set point formation is crucial and has permanent 
impact on the entire lifespan, the mechanisms underlying hypothalamic set point formation are 
largely unknown. Rodents provide a poor model for studies aimed to model the development 
the human HPT axis due to their strikingly different kinetics of HPT axis development that in 
rodents is represented by a relatively low developmental stage in the time of prenatal-postnatal 
transition. In contrast chickens have a relatively well-developed HPT axis at hatching and 
chicken embryos can separately and directly manipulated in the egg. Similarly to rodents, a 
time gap between the onset of HPT function and TH-mediated negative feedback also exists 
during the ontogeny of the chicken embryo. TH activating D2 and the inactivating D3 enzymes 
regulate hypothalamic TH availability and represent potential regulators of the feedback 
formation on TRH neurons but ontogenic aspects of this process are poorly understood.  
Tissue and cell-type specific regulation of TH action is especially intensely investigated in 
pathogenesis of non-thyroidal illness syndrome (NTIS) and mechanism of non-shivering 
thermogenesis (NST) in brown adipose tissue (BAT). Humoral and neuronal inputs to TRH 
neurons can overwrite normal feedback regulation in specific conditions and challenges like 
fasting, cold exposure, infection. The NTIS is a striking example of altered regulation of the 
HPT axis and occurs typically in critically ill patients. It is characterized by falling serum TSH 
and TH levels that is not followed by the upregulation of the HPT axis. Dissection of altered 
regulation of TH action in NTIS would be required to better understand the nature and 
potential treatment of this syndrome. The investigation of possible underlying mechanism of 
NTIS is frequently studied by bacterial lipopolysaccharide (LPS) induced systemic 
inflammation model in rodents.  
The BAT plays an instrumental role in energy dissipation via NST both in rodents and in 
human newborns and adults that put this tissue into the frontline of obesity research. The 
activation of this tissue is regulated by the hypothalamus via the sympathetic nervous system 
and results in uncoupling protein-1 (UCP1)-mediated mitochondrial uncoupling and heat 
generation in response to cold. TH and norepinephrine (NE) signalling play a synergistic role 
in NST and are responsible for sufficient lipogenesis, and adequate thermogenesis during cold 
exposure. Cold induced increase in D2-mediated local T3 generation facilitates the release of 
triglycerides from cell stores, accelerates cAMP response and UCP-1 expression. Deeper 
understanding of the regulation of local TH action in cold stressed BAT would be beneficial to 
find therapeutic targets for obesity treatment. 
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II. AIMS 
Our studies were performed to better understand the regulation of tissue-specific TH action. 
Specifically, we aimed to  
1. study how onset of negative feedback regulation of the HPT axis occurs 
- determine the period of the onset of TH-mediated negative feedback in the developing 
chicken hypothalamus 
- identify underlying mechanisms governing set point formation of the HPT axis 
 
2. study the regulation of TH availability in hypothalamic neuroendocrine axes 
- address TH inactivation in parvocellular neurosecretory neurons of rats 
- investigate how regulation of TH availability in neurosecretory neurons responds to 
challenges in a model of non-thyroidal illness syndrome  
 
3. generate a novel transgenic mouse model allowing the detection of tissue-specific TH 
action in live animals and tissue samples  
- characterize the Thyroid hormone action indicator mouse model  
- study the hypothalamic pathogenesis of the non-thyroid illness syndrome and interscapular 
BAT (iBAT) regulation using this model 
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III. MATERIALS AND METHODS 
1.1 Experimental Animals 
For ontogenic study of HPT axis development white Leghorn chicken embryos and posthatch 
chickens were obtained from Ceva-Phylaxia (Budapest, Hungary) and Wyverkens (Halle, 
Belgium). 
Posthatch chickens, adult, male Wistar rats (b.w. 220–250 g) and newly generated Thyroid 
Hormone Action Indicator (THAI) mice (FVB/Ant background) were kept under standard 
laboratory conditions with food and water ad libitum. 
1.2 Recombinant DNA technology and studies in cell cultures 
The recombinant DNA constructs, e.g. the  thyroid hormone action indicator construct 
(THAIC), chicken deiodinase promoter constructs and vectors containing inserts to generate 
RNA probes for in situ hybridization were prepared with standard techniques. DNA fragments 
were amplified with Taq or Vent polymerase driven polymerase chain reaction (PCR) and 
cloned to plasmid vectors. The newly prepared recombinant DNA was transformed to bacteria, 
and the correct clone was amplified in bacterial culture in the presence of antibiotics. 
To determine chicken Dio2 promoter responsiveness to Nkx2.1 U87 human glioma cells were 
maintained in DMEM supplemented with 10% FBS and were transfected using the calcium-
phosphate precipitation method. Briefly, transfection was carried out in a 24-well plate 
(Corning) using 1600 ng/well total DNA. 20.000 cells were seeded in each well one day before 
transfection, and the cells were harvested 48 hours later. 
To generate THAIC-HEK293T cell line HEK293T cells were cultured in DMEM+10% FBS 
and transfected with the THAIC targeting construct along with the pcGlobinSB100 transposase 
encoding vector in the presence of Lipofectamine 2000 reagent (Invitrogen) to allow Sleeping 
Beauty recombinase assisted genomic integration. Clone selection was performed in the 
presence of 150 µg/ml zeocin. Clones were cultured for 24 h in charcoal stripped FBS followed 
by the induction with 100 nM T3 for 24h in the presence of transiently coexpressed mouse 
TRα. 
1.3 Generation and characterization of Thyroid hormone action indicator 
(THAI) mouse model 
To generate targeting construct we cloned three copies of a DR-4 TRE (of the human DIO1 5’ 
FR) 5’ to the Herpes simplex virus thymidine kinase (TK) minimal promoter. This DNA 
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segment was linked upstream of the firefly luciferase coding region containing a codon-
optimized and methylation-resistant dCpG Luciferase-ShBle fusion protein upstream of an EF1 
pAn polyadenylation cassette. The targeting cassette was flanked by H19 insulators of 
pWHERE vector (Invivogen) and was cloned to pT2/BH vector (Addgene) between 
transposase inverted terminal repeat sequences. To generate transgenic mice the pronucleus of 
fertilized FVB/Ant oocytes was injected with a mixture containing the plasmid harbouring the 
targeting transposon cassette, along with in vitro transcribed mRNA encoding the Sleeping 
Beauty transposase. 
To assess copy number of transgene in the three generated founders (line #4,#18, and #23) 
fluorescence in situ hybridization was performed on lymphocytes, isolated from spleen under 
aseptic conditions. Insertion site was mapped with Splinkerette PCR technique on genomic 
DNA. Briefly a specially designed, universal Splinkerette oligonucleotide was used to amplify 
the region between the 5’ end of the transgenic cassette and the first BstYI restriction site, and 
the fragment was sequenced. 
Phenotypic characterization of the founders included measurement of serum TH levels, and 
body weight, while line #4, 11-week old animals were submitted to indirect calorimetric 
measurements in metabolic cages (PhenoMaster/LabMaster, TSE Systems GmbH, Bad 
Homburg, Germany) to determine metabolic parameters, highly dependent on TH status, and 
body composition analyses using an EchoMRI Whole Body Composition Analyzer (EchoMRI 
LLC, Houston, TX). 
1.4 Modulation and measurement of systemic TH levels 
For HPT axis developmental studies we injected E19 and P2 chickens intravenously 
(chorioallantoic blood vessel or leg vein respectively) with either 1µg T4, 200 ng T3 or vehicle 
(saline with 5mM NaOH) as control 8h before sampling.  
D3 activity was measured from microdissected ME samples of adult male Wistar rats, 
injected i.p. with 50 µg/of T3/100 g body weight (N = 9) or vehicle (N = 9) every second days in 
8 days. 
TH responsiveness of different THAI-Mice tissues was determined in vitro from tissue lysates 
and in vivo in live animals using T4 (injected i.p. with 5µg/day/mouse of L-T4 or vehicle 
control for 3 days), T3 (1 μg/g bw of L-T3 for one day) or hypothyroid treatment (0.1% 
sodium perchlorate and 0.5% methimazole in drinking water for 3 weeks combined with low 
iodine diet). 
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Serum free T4 and free T3 levels were measured with AccuLite CLIA Microwells kit 
according to the manufacturer’s instructions. Measurement is based on competitive 
chemiluminescence enzyme immunoassay methodology in a microplate format. 
1.5 LPS administration, a model of non-thyroidal illness syndrome in rodents 
For double-labelling immunohistochemistry (for D3 and hypophysiotropic peptides) 200g male 
Wistar rats were treated i.p. with LPS (250 µg/ 100g bw; E. coli 0127:B8, Sigma) for 12 hours, 
and transcardially perfused (see section III/1.6). 
THAI-Mice were treated i.p. with LPS (150 µg/animal; E. coli 0127:B8, Sigma) and 
decapitated 6, 8 and 10h after injection. Brain areas (arcuate nucleus + ME and PVN) were 
microdissected with punch needle from frozen sections placed on pre-cooled glass slides. 
Tissues were analysed in Taqman real-time quantitative PCR for luciferase and D2 or TRH 
expression (arcuate nucleus+ME or PVN, respectively). 
1.6 Immunohistochemistry and in situ hybridization 
Control and LPS treated Wistar rat brains were transcardially perfused either with 4% 
acrolein/2% PFA for detection of TRH or with 4% PFA (for GNRH, GHRH, CRH, TRH and 
somatostatin). Sections were double-labelled for D3 and hypophysiotropic peptides. After 
standard histological pretreatments, sections were reacted with the proper primary antibodies, 
overnight in blocking reagent. Biotinylated D3 antibody was detected with Alexa 488-
streptavidine secondary antibody, while primary antibodies against hypophysiotropic peptides 
were reacted with the appropriate fluorescent (Cy3) conjugated secondary antibodies. Confocal 
images were taken from the external zone of the ME using 60 X oil immersion objective, 
scanned by a Radiance 2100 confocal microscope (Bio-Rad Laboratories, Hemel Hempstead, 
UK). One randomly selected microscopic field (2600 µm2 each) from the external zone of ME 
of each animal was analysed, to quantify co-localization of D3 with the different peptides in 
the axon varicosities.  
Coronal 10 µm-thick sections through the anteroposterior extent of the ME of rats perfused 
with 4% PFA in PBS were subjected to immunofluorescent-labelling either for GnRH, D3 or 
RAB3 marker. Axon varicosities located in the external zone of the ME were imaged using a 
Nikon N-STORM super-resolution microscope system (Nikon Instruments Ltd.), and diameter 
of at least 500 immunoreactive clusters from each staining was measured with the NIKON NIS 
software. 
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Developmental expression of D2, Nkx2.1, D3 and proTRH mRNA was studied with isotopic in 
situ hybridization. 12µm native chicken brain coronal sections were cut on cryostat and 
mounted on glass slides. After pre-hybridization treatments one of the previously mentioned 
targets was hybridized overnight at 65oC with 500-1000bp, S35 labelled, antisense cRNA probe. 
Radioactive signal was detected after exposure for different time intervals with Kodak 
Autoradiographic Emulsion. Densitometric analysis of proTRH in situ hybridization signal was 
performed with ImageJ software on E19 and P2 sections, measuring mean silver grain density 
over chicken PVN. 
1.7 Deiodination assay 
Enzyme activity measurement is based on the determination of the amount of free I125 removed 
by D2 from the outer ring of I125 labelled T4, in vitro, in tissue lysates. The technique was used 
to determine D2 activity in developing chicken HT and MBH, and to detect changes in D2 
activity in cold stressed iBAT after sympathetic denervation. Snap frozen tissue samples were 
homogenized in PE buffer (0.1M potassium phosphate, 1 mM EDTA, pH 6.9) containing 
0.25M sucrose and 10 mM DTT). Equal amounts of total protein was mixed with assay buffer 
containing the I125 labelled T4, and incubated on 370C for the practical time. Amount of free 
I125 produced by a defined protein amount and known time was determined with gamma-
counter. 
1.8 Luciferase enzyme activity measurements in tissue samples and live 
animals 
Firefly luciferase enzyme activity can be determined in vitro from cell extracts, and from 
lysates of luciferase expressing tissues in microplate, by adding Luciferase Assay Reagent 
containing ATP and luciferin substrate, and measuring the light produced by the luciferase with 
Luminoskan Ascent luminometer. This technique was used to measure promoter activity of 
chicken Dio2 promoter in response to Nkx2.1 transcription factor in U87 glioma cell line, and 
measure luciferase activity in THAI-Mouse tissues in response to modulation of systemic TH 
levels.  
Luciferase activity was also detected and quantified in T3 treated, euthyroid, hypothyroid and 
cold stressed (24h at 4oC) live THAI-Mouse using IVIS Lumina II In vivo Imaging System. 
Live imaging was obtained in ketamine-xylazine anaesthetized mice whose fur over the iBAT 
and abdominal organs had been removed. D-luciferin was i.p. injected (150 and 750 µg/g bw, 
in PBS for the T3-treated and cold-stressed animals, respectively) 15 min before imaging. 
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Emitted light from the examined organ was quantitated in all animals using a region of interest 
(ROI) of identical size and shape.  
1.9 Taqman real-time quantitative PCR 
Gene expression changes were analysed with Taqman real-time PCR reactions on snap frozen 
tissues. TSHβ mRNA was detected in T3, T4 and vehicle treated E19 and P2 chicken 
pituitaries. In THAI-Mice, intact and denervated iBAT was analysed for D2, luciferase mRNA 
in response to cold stress and D2, luciferase, and TRH was quantified in punched brain areas of 
LPS treated mice. Total RNA was isolated with phenol-chloroform based column purification, 
with RNeasy Lipid Tissue Mini kit according to manufacturer’s instructions. 1 μg total RNA 
was reverse transcribed with High-Capacity cDNA Reverse Transcription Kit. 10ng cDNA was 
applied in each Taqman reaction, using Taqman Gene expression probe sets designed by 
Thermo Fisher Scientific, and Taqman Fast Universal PCR Mastermix. Gene expression of 
target genes was compared to GAPDH housekeeping gene. 
1.10 Statistics 
All data are shown as mean ± SEM. Groups were compared with two-tailed t-test. Multiple 
comparisons were made by one way ANOVA followed by Newman-Keuls or (above group 
number higher than 3) the Tukey post-hoc tests. Results of denervated iBAT experiments were 
analysed by Repeated Measurements ANOVA followed by Tukey post-hoc test. 
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IV. RESULTS 
1. Regulation of the onset of negative feedback in the developing chicken 
hypothalamus 
1.1 T4 induced negative feedback of the chicken HPT axis forms between E19 
and P2  
First we aimed to determine the period of onset of hypothalamic negative feedback, and we 
studied the responsiveness of proTRH expression in the PVN to T4 and T3 challenges in 
different developmental stages. In situ hybridization revealed that whereas exogenous T4 did 
not induce a statistically significant inhibition of proTRH expression in the PVN at embryonic 
day (E)19, T4 treatment was effective at two days after hatching (P2) and decreased proTRH 
expression by 25%. In contrast, proTRH expression responded to T3 treatment in both age 
groups and decreased proTRH expression by 30% in E19 chicken PVN and by 25% in P2. 
TSHβ mRNA expression in the pituitary responded to T4 and T3 in a similar age dependent 
manner and reduced TSHβ mRNA by 60% and 20%, respectively in P2 animals, while none of 
the treatments affected TSHβ expression in E19 pituitary. 
 
1.2 The role of hypothalamic TH metabolism in the onset of negative feedback 
on TRH neurons 
The presented difference between the responsiveness of TRH expression in the PVN to T4 and 
T3 at E19 suggested that developmental changes in hypothalamic TH activation and 
inactivation could be an important factor in set point generation. First we focused on the local 
TH activation and assessed the expression of D2 mRNA in the chicken hypothalamus with 
isotopic in situ hybridization during development before and after the onset of negative TH 
feedback. Faint D2 hybridization signal was observed well before set point formation, in E13 
β-tanycytes in the “posterior” hypothalamic sections, and in perivascular elements throughout 
the hypothalamus. In P2 animals, the D2 mRNA expression appeared in β-tanycytes in 
“anterior” regions and expanded to α-tanycytes generating an expression pattern along the 
ependymal layer of the third ventricle. D2 activity was also assessed both in the MBH and in 
the MBH-lacking hypothalamic region at stage E15, E18, and P2 with in vitro deiodination 
assay. D2 activity showed an 11.6-fold increase in the MBH and a markedly lower but 
significant 3.9-fold increase in the MBH-lacking hypothalamic sample when P2 samples were 
compared to those of E15. 
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We also assessed the expression and protein level of inactivating D3 but could not observe 
marked changes before and after the period of negative feedback formation nether in neurons 
nor in tanycytes which are expressing D3 abundantly in all investigated ages. 
 
1.3 Nkx2.1 mRNA was expressed in the chicken tanycytes but not in 
perivascular elements 
We also tried to identify factors that could be involved in the expression of D2 in the 
developing hypothalamus. Since the Nkx2.1 developmental transcription factor can trans-
activate thyroid-specific genes and human DIO2 gene, it is a potential regulator of chicken D2 
expression. In situ hybridization revealed, that distribution of Nkx2.1 expression overlapped 
with that of D2 in E13 and P2 tanycytes both in the floor and the wall of the third ventricle, but 
Nkx2.1 was absent in D2-expressing cells of the perivascular space. To assess whether the 
coexpression of Nkx2.1and D2 in chicken tanycytes could lead to Nkx2.1-mediated 
transcriptional activation of the chicken Dio2 gene, we performed promoter assay in U87 
glioma cells. Nkx2.1 coexpression increased transcription of the cDio2 3.6kb and 588 bp long 
5’flanking regions by ~4-fold and 1.8-fold, respectively. The empty pGL3-basic vector 
remained unresponsive. Sequence analysis of the used cDio2 5’ FR fragment indicated five 
potential Nkx2.1 binding sites relative to the transcriptional start site (-18, -2872, -2587: 
TCAAGG; -2321, -1671; TCAAGT). 
 
2. Thyroid hormone availability in parvocellular neurosecretory neurons of the rodent 
hypothalamus 
2.1 Distribution and subcellular localization of D3 in the rat hypothalamus 
Neurons cannot generate T3 so they need to import T3 from glial cells. Intracellular level of T3 
is fine tuned in neurons by D3-mediated T3 degradation. We aimed to understand how this 
process works in neurosecretory neurons. Using light microscopic immunohistochemistry D3-
immunoreactivity appeared as small puncta distributed unevenly in the hypothalamus. The 
highest density was observed in the external zone of the ME, where the axons of the 
hypophysiotropic neurons accumulated around the portal capillary system. D3 
immunoreactivity was also observed in most hypothalamic regions including those known to 
project to the ME (i.e. the medial preoptic area, paraventricular and arcuate nuclei), although 
less intense than the ME. The punctate appearance in these regions suggested localization in 
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axons similar to that observed in axons in the ME as no D3 immunoreactivity was identified in 
neuronal perikarya.  
Previous ultrastructural studies of our group localized D3 to dense core vesicles (DCV) in axon 
varicosities. We continued this study by determining the topology of D3 in the DCV in the 
outer zone of the hypothalamic ME using N-STORM superresolution microscopy. Using 
immunofluorescent-labelling we found that the C-terminal portion of D3 formed 
immunoreactive clusters of 83.9 nm, that was significantly larger than clusters containing 
intravesicular GnRH clusters of 65.6 nm and slightly bigger than clusters containing RAB3 
(81.4 nm), a protein covering the outer surface of the DCV. Thus N-STORM microscopy 
revealed that C-terminal active center of D3 is localized outside of the DCV surface and faces 
the cytoplasm, representing the main TH inactivation locus in the axon terminals. Importantly, 
DCV associated D3 is catalytically active in the axon terminals, as proved by the 
demonstration of authentic D3 activity using deiodinase assay on microdissected rat ME 
samples containing the axonal compartment of hypophysiotropic neurons. Furthermore, D3 
activity was upregulated by ∼4-fold in hyperthyroid rats. 
 
2.2 Phenotype of D3-immunoreactive hypophysiotropic terminals and 
distribution of D3 in neurosecretory neurons under pathophysiological 
conditions 
To determine the phenotype of the D3-containing axon terminals in the ME, co-localization of 
D3-immunoreactivity with hypophysiotropic releasing or inhibiting hormones was performed 
with double-labelling immunofluorescence and confocal microscopy. The D3-immunoreactive 
loci appeared as small islands within axon varicosities. D3-immunoreactivity was observed in 
GnRH (71.8±3.8%), CRH (63.2±7.5%), GHRH (64.2±2.7%) and TRH (26.6±5.0%) axon 
terminals, mostly in distal varicosities and terminal portions. The lower D3 occurrence in TRH 
axons was significantly different from that observed in GnRH, CRH and GHRH axons, and D3 
was absent from somatostatin (SST)-immunoreactive axon varicosities and magnocellular 
neurons. We demonstrated that uptake of T3 is possible to hypophysiotropic axon varicosities 
as monocarboxylate transporter 8 (MCT8) TH transporter was presented on all types of axon 
terminals. 
D2-mediated TH activation capacity in MBH is known to be increased in LPS-induced NTIS 
model, and we aimed to assess how the T3 degradation capacity of parvocellular neurons is 
affected by this challenge. We studied the distribution of D3 in axon terminals of parvocellular 
neurons 12h after i.p. LPS injection. LPS significantly decreased the number of D3 positive 
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varicosities both in GHRH (10%) and CRH (25%) containing axons suggesting deceased T3 
degradation and elevated T3 level in these compartments. Importantly, neither TRH, nor 
GnRH-containing axons were affected. The unchanged axonal D3 content of TRH neurons 
after LPS challenge along with the similarly unchanged number of MCT8 positive terminals of 
these neurons are indicating that TRH neurons are programmed to rely on hypothalamic T3 
without significant further intracellular modulation of their T3 content. 
 
3. Generation and characterization of Thyroid hormone action indicator mouse model 
3.1 Generation 
TH action is a net result of the activity of a complex molecular machinery that includes TH 
transport, TH metabolism and TR-mediated nuclear events. To asses tissue-specific 
mammalian TH action in an in vivo context we generated a TH action indicator (THAI) mouse 
model and started to use in the investigation of TH signalling in the hypothalamus and iBAT. 
Mice were generated to access tissue-specific TH action by expression of firefly luciferase 
reporter gene, which was made TH sensitive by triplets of TRE elements of hDIO1 gene. (For 
detailed description of targeting DNA construct see section III/1.2) Genomic insertion of the 
transgenic cassette was performed with pronuclear injection in the presence of in vitro 
transcribed mRNA encoding the Sleeping Beauty transposase. 
Three transgenic mouse lines were generated, i.e. #4, #18 and #23. Fluorescence in situ 
hybridization revealed that homozygotes of all lines harbour two copies of the THAI transgenic 
construct indicating that a single copy was inserted into founders. Adult animals of the three 
founders are biochemically euthyroid with normal fT4 and fT3 serum concentrations, and have 
normal bodyweight. Splinkerette PCR revealed, that the reporter cassette was inserted into a 
region of repeat family L1 into the genome of THAI-Mouse line #4 indicating that the cassette 
did not alter the structure of any endogenous gene. In accordance, the animals did not exhibit 
any identifiable phenotype. In THAI-Mouse #4, neither body weight nor systemic parameters 
highly dependent on thyroid status (lean body mass, fat mass, respiratory exchange ratio /RER/ 
and volume of oxygen consumption /VO2/) were significantly different from wild-type 
controls.  
 
3.2 Characterization of TH responsiveness in THAI-Mouse lines 
Various tissues of homozygote male mice with modulated TH status were harvested and 
processed for measurement of luciferase activity. In all lines, basal luciferase activity varied 
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extensively among different tissues. Differences of ~6-orders of magnitude were observed 
between liver and testicle, while values of most tissues fall into a range within 2-orders of 
magnitude. These differences are likely to reflect the overall transcriptional activity of the 
DNA insertion site, which is cell-specific. Line #4 exhibited a great deal of variability in tissue 
responsiveness to TH when treated with L-T4, from 0.8-fold in the testicle, 1.5-2 fold in brain 
(hypothalamus, hippocampus, cerebellum, cortex), to 64-fold in iBAT, while other highly 
responsive tissues were skeletal muscle, heart, mandibular salivary gland (MSG) and skin (4-
11-fold). The pattern of TH responsiveness was distinct in the other THAI-Mice, with line #23 
only exhibiting a ~7-fold L-T4 responsiveness in the iBAT and no detectable activity at all in 
this tissue of line #18. However, line #23 and #18 exhibited marked response to TH in the 
pituitary, and line #18 showed the highest brain baseline activity. 
Thus, line #4 permits the study of TH action in a wide variety of tissues, whereas the two other 
lines hold additional value for specific applications represented by high reporter response in the 
pituitary (lines #18 and #23) and higher basal activity in the brain (#18) due to their different 
insertion sites. 
We also tested the responsiveness of the THAI-Mouse #4 to a decrease in tissue TH action. 
Animals were chemically rendered hypothyroid and luciferase activity was measured in 
various tissues and brain regions. Approximately 2-3 fold decrease in TH signalling could be 
detected in different brain regions (e.g. the hypothalamus and cerebral cortex), the liver and in 
white blood cells, 4-6 fold in iBAT, pituitary, heart, bone and 10-fold in small intestine. Thus 
THAI-Mouse allows detection of tissue hypothyroidism in various tissues. 
 
3.3 TH signalling can be assessed in the live THAI-Mouse 
Tissues like iBAT, small intestine, MSG, skin, saccus caecum can be examined also in live 
animal, using in vivo bioluminescence imaging. Hypo-, eu-, and hyperthyroid #4 mice were 
analysed in anesthesia 15 min after i.p. D-luciferin injection. In the duodenum and jejunum, 
hypothyroidism decreased luciferase activity by ~80%. A single L-T3 injection 24h before 
imaging induced luciferase activity in iBAT by ~9-fold, in the small intestine by ~3-fold, and 
to a lesser extent in foot pads and tail.  
 
3.4 Application of THAI-Mouse to study tissue-specific TH signalling 
The THAI-Mouse allowed us to address the pathogenesis of NTIS by direct assessment of 
tissue-specific TH action in discrete brain regions. LPS induced NTIS evoked ~2 fold increase 
in D2 mRNA level in microdissected MBH of #23 THAI-Mouse in all investigated time points 
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(6, 8, 10h after i.p. LPS injection), that was followed by the increase of luciferase reporter 
expression reaching significance after 8h, at the time point when TRH expression decreased 
significantly by ~50% in PVN. These findings revealed that during the pathogenesis of NTIS 
D2-mediated increase of local TH activation affects TH signalling in the MBH that contributes 
to the down-regulation of the HPT axis by decreasing TRH expression in PVN. 
The iBAT is under synergistic control of NE and TH signalling and is under the regulation of 
the central nervous system. In live #4 THAI-Mouse we could gauge physiological changes in 
TH availability, and detected increased TH action after 9 and 24h cold stress in iBAT. A 3.2-
fold increase in bioluminescence signal was observed in iBAT after 24h of cold exposure, 
while foot pad skin remained unchanged. Similar induction of TH action was measured in 
dissected, cold stressed iBAT samples. We used this model to study the role of NE signalling 
in the regulation of TH action of the iBAT. Unilateral sympathetic denervation did not 
influence basal D2 activity and luciferase mRNA, indicating that baseline TH action is less 
dependent on the sympathetic input. Denervation resulted in diminished response of iBAT to 
cold stress, and prevented the 9-hour cold exposure induced ~2-fold increase of NE content, 9-
fold increase in D2 expression and 18-fold acceleration in D2 activity that induced only ~2.7-
fold increase in luciferase mRNA level in the intact iBAT lobe. Therefore we concluded that 
basal and cold-induced TH actions are differently regulated by the sympathetic nervous 
system. 
The THAI-Mouse is also useful to test the performance of TR isoform-specific TH analogues, 
called thyromimetics, which are developed to evoke the beneficial effects of TH (e.g. lowering 
of cholesterol and induce weight loss) without unwanted cardiac effects. Treatment of #4 
THAI-Mouse with TRβ isoform-specific GC24 compound increased luciferase activity by 
~2.5-fold in TRβ dominant liver however it did not increase TH signalling in the TRα 
dominant heart. 
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V. CONCLUSIONS 
The presented results aimed to contribute to the better understanding of mechanisms 
underlying TH action in the developing and adult brain and in related peripheries along with 
the generation of a novel transgenic mouse model for these studies. 
TH-mediated hypothalamic set point formation is poorly understood despite its fundamental 
impact on TH economy and consequently on tissue function persisting throughout the entire 
lifespan. Our studies in chicken model determined the period of set point formation and 
demonstrated that tight regulation of local hypothalamic TH availability via a dramatic 
developmental increase in hypothalamic D2-mediated T3 generation plays a crucial role in the 
formation of negative feedback on TRH neurons. Since maternal TH status impacts fetal TH 
availability and altered TH levels during development could result in shifted HPT set point 
with persisting effects, our data could provide novel arguments to the ongoing debate whether 
maternal TH levels should be routinely monitored during human pregnancy, especially in the 
sensitive period when set point of the HPT axis is formed. Studies on primates would be useful 
to confirm the importance of the presented mechanism in higher vertebrates. 
Neurosecretory neurons represent a major hypothalamic target of TH. The revealed abundant 
presence of functional D3 in axon terminals of hypophysiotropic parvocellular neurons on the 
outer surface of dense core vesicles represents a novel regulation of neuroendocrine axes by 
TH. We could classify two types of axon terminals based on their D3 content. Number of D3-
positive axon varicosities was found highly variable in different neurosecretory systems and 
was subjected to intense and quick changes in response to challenges like bacterial LPS-
induced inflammation. This indicated the existence of axon-type specific regulation of 
intracellular T3 availability in axon terminals of neurosecretory neurons. Tanycyte processes in 
the median eminence represent the main source of hypothalamic T3 while the cell bodies of 
hypophysiotropic neurons are located in distinct brain nuclei. Thus it can be hypothesized that 
the pathway along TH can gain access to the nuclear compartment of these neurons involves 
uptake by axon terminals in the median eminence and retrograde transport along 
neurosecretory axons to the soma. We suggest that D3-mediated T3 inactivation in the 
varicosities can serve as a gate keeper that dynamically regulates the amount of T3 reaching 
the nucleus by retrograde transport. Furthermore D3 may have also local effect on axonal 
neurosecretion by affecting mitochondrial biogenesis, and function, however more studies are 
still needed to support this hypothesis. Monocarboxylate transporter 8-mediated axonal T3 
uptake and neuron-type specific regulation of intracellular T3 concentration via D3 in the 
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rodent median eminence could represent a novel pathway for the modulation of hypothalamic 
control of reproduction, growth, stress and metabolism. 
The generated Thyroid Hormone Action Indicator (THAI) Mouse model has the potential 
greatly facilitate the investigation of tissue-specific TH action by providing an unbiased in vivo 
model for these studies. The THAI-Mouse model is based on a firefly luciferase reporter and 
uses a fully endogenous set of regulators of TH action. The model allows quantification of TH 
action in a live mammal for the first time along with the assessment of TH action in samples 
originating from various brain regions and peripheral tissues. While endogenous TH responsive 
genes are also controlled by various non-TH related factors, THAI-Mouse authentically reports 
TH action. The model can detect endogenous changes in TH availability and reports both tissue 
hyper- and hypothyroidism in the brain and in peripheral tissues. Using this model we could 
demonstrate that TH action is tissue-specifically regulated in hypothalamic subdivisions during 
the development of infection-induced non-thyroidal illness syndrome. The model was also used 
to better understand TH regulated mechanism in the cold-induced iBAT. Moreover our studies 
demonstrated, that THAI-Mouse could be used in testing TR isoform-selective compounds in 
the presence of endogenously expressed receptors, and could support the efforts to develop 
thyromimetics to treat obesity, and high cholesterol levels. THAI-Mouse could be also highly 
useful to study tissue hypothyroidism during TH replacement therapy. These studies can 
provide novel data to advance the ongoing debate on TH replacement that could potentially 
affect future treatment of tens of millions of patients worldwide. 
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